What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 3
Featuring Gary Goldenberg, MD | Co-Director |
Assistant Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Director of Center for Clinical and Cosmetic Research
Voluntary Professor, Dermatology
University of Miami, Miller School of Medicine
Miami, FL
In this presentation, Gary Goldenberg, MD and Mark Nestor, MD, PhD, provided valuable insights into botulinum toxin (Botox) injections, collagen biostimulators, androgenetic alopecia (AGA) treatments, and innovative aesthetic devices for 2025. They began by discussing Botox injections, emphasizing that while all Type A toxins share the same mechanism of action, variations in results arise from differences in molecular potency, dosage, patient-specific factors (such as age, gender, and muscle mass), genetics, and injection technique. Using detailed diagrams, they highlighted optimal injection sites to achieve desired outcomes and noted how targeting the correct muscles not only influences facial aesthetics but may also impact mood through facial feedback.
The discussion then moved to collagen biostimulators, including poly-L-lactic acid (PLLA), calcium hydroxyapatite (CaHA), and cross-linked hyaluronic acid (HA). The presenters reviewed clinical studies, case results, potential mechanisms, and possible side effects of these biostimulators. For AGA, a variety of treatment options were explored, ranging from platelet-rich plasma and stem cells/exosomes (often paired with microneedling) to red light therapy, topical medications, vitamins, and low-dose oral minoxidil.
Lastly, the presentation introduced two cutting-edge aesthetic devices. RF microneedling was highlighted for its versatility in skin tightening and fat reduction, particularly in the infraorbital and submental regions. The Thulium 1928 nm laser was showcased as a promising tool for effectively treating pigmentary disorders, demonstrating excellent clinical results.
More from this series
Dermatology
Say ‘No’ to Spontaneity: Treating Chronic Spontaneous Urticaria
Featuring Dawn Merritt, DO | Mark Lebwohl, MD | Marc Serota, MD
Dermatology
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 2
Featuring Seemal Desai, MD | Mark Lebwohl, MD | Dawn Merritt, DO | Joshua Zeichner, MD
Dermatology
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 1
Featuring Darrell Rigel, MD, MS | Brian Berman, MD, PhD | David Cohen, MD, MPH
Related CME



Related Media
Powered by Polaris TM
Aesthetics
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 3Video
Gary Goldenberg

Dermatology
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 1Video
Brian Berman

Dermatology
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 1Video
Darrell S. Rigel

Dermatology
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 1Video
David E. Cohen